Trial Profile
Evaluation of weekly risedronate treatment in postmenopausal women.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2011
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 01 Dec 2011 Results published in Gynecological Endocrinology.
- 05 Nov 2010 New trial record.